Navigation Links
Receptors involved in corneal clarity identified

The researchers at the Aberdeen University have found out molecules that could aid in the treatment of cancer, heart diseases and other serious disorders//.

The expression of this molecule, sflt-1, a free-floating receptor for vascular endothelial growth factor A, prevents the formation of vision obstructing blood vessels, thus keeps the cornea clear.

According to the researchers, this discovery could help in the development of new drugs, new therapies for eye diseases and eye injuries. The Aberdeen team and colleagues at the Medical College of Georgia and the University of Kentucky in the US conducted this research.

Dr Martin Collinson, senior lecturer at the University of Aberdeen, said, "The molecule is an amazing finding". He added: "The cornea is widely used by scientists who hope to study how blood vessels grow or how to inhibit the growth of new blood vessels. "This knowledge will help to treat diseases like cancer, heart disease, rheumatoid arthritis, stroke and eye disorders like macular degeneration. "The cornea is our window on the world. If it contained blood vessels it would not be transparent and we would not be able to see. "If you study a normal eye you will see blood vessels in the whites of the eye but these stop at the cornea."

The cornea could get vascularised or form blood vessels due to disease or injury. Tumors are able to grow due to their capacity to attract blood vessels. Hence, vascularisation is crucial in diseases like cancer.
GYT
'"/>




Page: 1

Related medicine news :

1. Effects Of Certain Food Related To Single Pain Receptors
2. Inhibitor That Blocks Host Receptors Found To be Effective In Treating Anthrax
3. Max Planck Researchers Incorporate Odorant Receptors into Artificial Membranes
4. Nitric oxide involved in high blood pressure
5. Scientists locate key hormone involved in appetite control
6. Risks involved in Procedural Sedation
7. Toxin causing Gastrointestinal problems identified
8. Gene Variant associated with Schizophrenia identified
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is ... Road To Recovery® program to drive cancer patients to and from their cancer treatments. ... the highest quality of life and ongoing independence. Getting to and from medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... is proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon ... beautiful women in the world, and the most handsome men, look naturally attractive. ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016  In a startling report released today, ... their residents by lacking a comprehensive, proven plan to eliminate prescription ... definitive ranking of how states are tackling the worst drug crisis ... four states – Kentucky , New ... Vermont . Of the 28 failing states, three – ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... - Forecast to 2022" report to their offering. ... to date financial data derived from varied research sources to ... potential impact on the market during the next five years, ... of sub markets, regional and country level analysis. The report ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
Breaking Medicine Technology: